You just read:

PharmaMar and Specialised Therapeutics Asia Sign Licensing and Marketing Agreement for Lurbinectedin Covering Australia, New Zealand and Several Asian Countries

News provided by

PharmaMar, SA

May 18, 2017, 09:00 ET